A new scale for grading ocular adverse events in oncology trials addresses ambiguities in CTCAE version 5 and includes dose modification recommendations. The scale, implemented in the I-SPY 2 trial, ...

HSDD affects 40%-55% of postmenopausal women, often due to hormonal changes, impacting sexual desire and quality of life.

A common, non-invasive skin imaging technique can predict which melanoma patients face a higher risk of metastasis as accurately as current methods that require analyzing tumor samples after surgery.

A final discussion point is real-world applicability. Although PHAROS presents exceptional PFS, the modest difference between PFS and OS suggests that resistance remains a major hurdle. As with other ...

Dual art therapy, combining music and painting, significantly improved symptoms, cognitive function, and quality of life in ...

Celecoxib improves disease-free and overall survival in ctDNA-positive stage III colon cancer patients when combined with ...

The IRA requires health plans serving the Part D market to cover all negotiated drugs, and it has been predicted that CMS ...

Zevaskyn, the first gene therapy for recessive dystrophic epidermolysis bullosa, showed significant wound healing in phase 3 ...

As treatment for schizophrenia changes, LAIs are becoming increasingly important as maintenance therapy. Teva's pursuit of an ...

The Managed Healthcare Executive 2025 State of the Industry survey is a timely snapshot of how payers, providers and pharmacy ...

Venclexta-azacitidine combination offered better responses with less hospitalization and lower symptom burden compared with ...

High consumption of ultra-processed foods elevates the risk of early-onset colorectal cancer, highlighting the need for ...